AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV) is a Healthcare stock tracked by StreetAlpha. It last closed at $265.76 on Oct 5, up 1.12% on the day. ABBV reports earnings on Fri, Oct 30, 2026. The average 12-month price target from 17 analysts is $286.12 (+7.7% from the last close), with a high of $320.00 and a low of $247.00. Analyst consensus is Strong Buy, based on the latest ratings from 17 firms (14 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ABBV, 0% of them bullish and 100% bearish. In the past 30 days there were 18 dark pool prints totaling $27.9M, the largest $12.7M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 17 analysts who set a price target on ABBV in the past 90 days. The average target is $286.12, with a high of $320.00 and a low of $247.00, compared with the last close of $265.76.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 6 | Scotiabank | Maintained | Buy | $320 |
| Sep 10 | HSBC | Maintained | Buy | $315 |
| Aug 20 | Piper Sandler | Target raised | Buy | $298 → $303 |
| Aug 17 | Wells Fargo | Target raised | Buy | $295 → $300 |
| Aug 13 | Wolfe Research | Upgrade | Buy | $300 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABBV is in one of them and how their past ABBV trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ABBV in an article yet. Here's the latest on the wider market.